Evaluation of platelet membrane glycoproteins in coronary artery disease: consequences for diagnosis and therapy
M Gawaz, FJ Neumann, A Schömig - Circulation, 1999 - Am Heart Assoc
… blood to adhesive molecules of the subendothelium. Platelet … to the damaged vessel wall
is the first step in hemostasis and … The therapeutic effect of fibrinolysis in acute myocardial …
is the first step in hemostasis and … The therapeutic effect of fibrinolysis in acute myocardial …
[PDF][PDF] Antithrombotic medications and their impact on fibrin clot structure and function
A Undas, M Zabczyk - J Physiol Pharmacol, 2018 - portalwiedzy.cm-uj.krakow.pl
… Pharmaceutical agents affecting blood coagulation have … Available data show no effect of
clopidogrel on plasma clot … enhance fibrinolysis in patients with coronary artery disease. J …
clopidogrel on plasma clot … enhance fibrinolysis in patients with coronary artery disease. J …
Antithrombotic drugs—pharmacology and perspectives
T Li, D Yuan, J Yuan - Coronary artery disease: Therapeutics and drug …, 2020 - Springer
… this process is called fibrinolysis. Normally, hemostasis and fibrinolysis are finely regulated
… poor metabolism of clopidogrel, resulting in inadequate drug effect and ultimately leading to …
… poor metabolism of clopidogrel, resulting in inadequate drug effect and ultimately leading to …
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
AO Maree, DJ Fitzgerald - Circulation, 2007 - Am Heart Assoc
… that forms a nidus for coagulation. Fibrin generation and … in patients with stable coronary
artery disease who were taking … inflammation, and enhances fibrinolysis. Indeed, aspirin does …
artery disease who were taking … inflammation, and enhances fibrinolysis. Indeed, aspirin does …
… platelet dependent thrombosis and the role of dual antiplatelet therapy on blood thrombogenicity in patients with type 2 diabetes mellitus and coronary artery disease
G Viswanathan - 2014 - theses.ncl.ac.uk
… clopidogrel to standard treatment will reduce blood thrombogenicity in T2DM and stable
coronary artery disease (… by expressing adhesion molecules for leucocytes such as vascular cell …
coronary artery disease (… by expressing adhesion molecules for leucocytes such as vascular cell …
Platelet aggregometry testing: molecular mechanisms, techniques and clinical implications
K Koltai, G Kesmarky, G Feher, A Tibold… - … journal of molecular …, 2017 - mdpi.com
… Junctional adhesion molecule A (JAM-A) is rapidly phosphorilated during platelet activation
by … in hemostasis: thrombin generation, clotting, clot retraction and fibrinolytic activation [81]. …
by … in hemostasis: thrombin generation, clotting, clot retraction and fibrinolytic activation [81]. …
Platelet function testing in cardiovascular diseases
AD Michelson - Circulation, 2004 - Am Heart Assoc
… Formation of the hemostatic plug at sites of vascular injury is … stable coronary artery disease,
7 human percutaneous coronary … The failure of clopidogrel to prevent an arterial thrombotic …
7 human percutaneous coronary … The failure of clopidogrel to prevent an arterial thrombotic …
[PDF][PDF] Aspirin plus clopidogrel for angina pectoris in coronary heart disease patients
X Zhang, J Chen, M Ding, N Zhang - Int J Clin Exp Med, 2018 - e-century.us
… Effect of clopidogrel on adhesion molecules, hemostasis, and fibrinolysis in coronary
heart disease. J Cardiovasc Pharmacol 2008; 51: 616-620. [12] Valgimigli M and Biscaglia S. …
heart disease. J Cardiovasc Pharmacol 2008; 51: 616-620. [12] Valgimigli M and Biscaglia S. …
Clinical importance of antiplatelet drugs in cardiovascular diseases
J Papp, P Kenyeres, K Toth - Clinical Hemorheology and …, 2013 - content.iospress.com
… Platelets play an important role both in normal hemostasis … : percutaneous coronary intervention
[50, 61, 68], fibrinolysis [… considered in stable coronary artery disease in clopidogrel non-…
[50, 61, 68], fibrinolysis [… considered in stable coronary artery disease in clopidogrel non-…
Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery disease
… range, FX06 in vitro mildly affects hemostasis by way of mostly … in patients receiving
aspirin and clopidogrel is warranted. … CD 31 (platelet/endothelial cell adhesion molecule [PECAM)-1]…
aspirin and clopidogrel is warranted. … CD 31 (platelet/endothelial cell adhesion molecule [PECAM)-1]…